Metoprolol Holding Parameters
Metoprolol (or other beta-blockers) should be held when bradycardia or hypotension is present, with numeric thresholds of heart rate <50 beats/min or systolic blood pressure (SBP) <90 mm Hg used in a peri-ICU beta-blockade protocol. [1] Beta-blockers should also be avoided when heart block or active congestive heart failure with pulmonary edema is present in the same protocol. [1]
Hemodynamic Thresholds
- Hold beta-blockade for heart rate <50 beats/min. [1]
- Hold beta-blockade for SBP <90 mm Hg. [1]
Conduction and Rhythm Criteria
- Hold beta-blockade for evidence of heart block on electrocardiogram (EKG). [1]
Clinical Contraindications
- Hold beta-blockade for active congestive heart failure with pulmonary edema. [1]
- Hold beta-blockade for cardiac index <2.5 or need for inotropic support, when present in the protocol’s contraindication list. [1]
- Hold beta-blockade for active wheezing or bronchospasm. [1]
Medication Label Contraindication Signals
- Metoprolol labeling lists contraindications consistent with clinically significant bradycardia and conduction disease, including severe bradycardia (greater than first-degree heart block) or sick sinus syndrome without a pacemaker. [2]
- Metoprolol labeling includes hypotension as a contraindication. [5]
Monitoring Requirements Around Administration
- If beta-blockade is ordered, SBP and heart rate should be checked before and after administration, and hold parameters should be obtained per local medication guidance. [3]
Practical Hold Interpretation
- Holding metoprolol for SBP <90 mm Hg or heart rate <50 beats/min is supported by the peri-ICU protocol’s explicit hold thresholds. [1]
- Holding metoprolol for heart block or wheezing/bronchospasm aligns with the same protocol’s explicit contraindication criteria. [1]
Medication-Specific Safety Considerations
- Metoprolol adverse effects include bradycardia and hypotension, which are the primary physiologic triggers for holding therapy in inpatient beta-blocker protocols. [3]
- Metoprolol labeling emphasizes monitoring for hypotension and marked bradycardia during use. [4]
References for Source Material
The thresholds above are taken from an institutional peri-ICU beta-blockade management guideline and drug label or medication guidance documents for metoprolol safety monitoring and contraindications. [1]-[5]